Biotech raises $315 million in IPO, surpassing $250M target
September 13, 2024 at 09:47 AM EDT
Bicara Therapeutics, led by CEO Claire Mazumdar, develops cancer drugs.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |